Early erythropoietin influences both transfusion and ventilation need in very low birth weight infants

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 24, Issue 8, 2011, Pages 1060-1064

  Tempera, A ^a   Stival, E ^a,b   Piastra, M ^b   De Luca, D ^b   Ottaviano, C ^a   Tramontozzi, P ^a   Marconi, M ^a   Cafforio, C ^a   Marcozzi, P ^a   Rossi, N ^a   Buffone, E ^a  

^a SCamillo Forlanini General Hospital   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Erythropoietin; hemotransfusions; mechanical ventilation; prematurity anemia; VLBW infants

Indexed keywords

ALPHA TOCOPHEROL; FOLIC ACID; IRON; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; ARTIFICIAL VENTILATION; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EARLY INTERVENTION; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; FEMALE; GESTATIONAL AGE; HUMAN; LENGTH OF STAY; MALE; NEWBORN; NEWBORN INTENSIVE CARE; OUTCOME ASSESSMENT; PREMATURITY; PREMATURITY ANEMIA; PRIORITY JOURNAL; VERY LOW BIRTH WEIGHT; VITAMIN SUPPLEMENTATION;

ANEMIA; BLOOD TRANSFUSION; CASE-CONTROL STUDIES; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; ERYTHROPOIETIN; FOLIC ACID; HEMATINICS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; INTENSIVE CARE UNITS, NEONATAL; IRON; LENGTH OF STAY; RESPIRATION, ARTIFICIAL; TREATMENT OUTCOME;

EID: 79959950552     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2010.545917     Document Type: Article

References (10)

1. Strauss RG. Erythropoietin and neonatal anemia. NEJM 1994; 330:1227-1228. (Pubitemid 24121993)
2. Aher SM, Ohlssom A. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2006;3:CD004865.
3. Ohls RK. Transfusions in the preterm infant. NeoReviews 2007;8:e377-e386.
4. Haiden N, Klebermass K, Cardona F, Schwindt J, Berger A, Kohlhauser-Vollmuth C, Jilma B, Pollak A. A randomized, controlled trial of the effects of adding vitamin b12 and folate to erythropoietin for the treatment of anemia of prematurity. Pediatrics 2006;118:180-188. (Pubitemid 46071161)
5. Donato H, Vain N, Rendo P, Vivas N, Prudent L, Larguía M, Digregorio J, Vacchiarelli C, Valverde R, García C, et al. Effect of early versus late administration of human recombinant- erythropoietin on trarequirements in premature infants: results of a randomized, placebo-controlled, multicenter trial. Pediatrics 2000;105;1066-1072. (Pubitemid 30243785)
6. Maier RF, ObladenM, Kattner E, Natzschka J, Messer J, Regazzoni BM, Speer CP, Fellman V, Grauel L, Groneck P, et al. Highversus- low-dose eythropoietin in ELBW infants. The European Multicenter rhEPO study group. J Pediatr 1998;132: 866-870.
7. Bierer R, Peceny MC, Hartenberger CH, Ohls RK. Erythropoietin concentrations and neurodevelopmental outcome in preterm infants. Pediatrics 2006;118:e635-e640. (Pubitemid 46089988)
8. Maier RF, Obladen M, Muller-Hansen I, Kattner E, Merz U, Arlettaz R, Groneck P, Hammer H, Kö ssel H, Verellen G, et al. European Multicenter Erythropoietin Beta Study group. Early treatment with erythropietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. J Pediatr 2002;141:8-15. (Pubitemid 34774944)
9. Ohls RK, Hunter DD, Christensen RD. A randomized, doubleblind, placebo-controlled trial of recombinant erythropoietin in treatment of the anemia of bronchopulmonary dysplasia. J Pediatr 1993;123:996-1000. (Pubitemid 23353268)
10. Brown MS, Baron AE, France EK, Hammam RF. Association between higher cumulative doses of recombinant erythropoietin and risk for retinopathy of prematurity. JAAPOS 2006;10:143-149.